The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Tumor profiling of 1,306 gastric and esophageal carcinomas and different treatment options.
John Thomas Miura
No relevant relationships to disclose
Joanne Xiu
Employment or Leadership Position - Caris Life Sciences
Fabian McCartney Johnston
No relevant relationships to disclose
Kiran Turaga
No relevant relationships to disclose
T. Clark Gamblin
No relevant relationships to disclose